Congress logo
Back to Conference page

The 13th World Conference on Tobacco OR Health

Building capacity for a tobacco-free world

July 12-15, 2006, Washington, DC, USA



Thursday, July 13, 2006 - 12:00 PM
13-158

Multicomponent Intensive Group Therapy (MIGT) for smoking cessation in Argentina: the effectiveness of a “real world” program

Verónica Schoj, MD, Family Medicine Service, Hospital Italiano de Buenos Aires, GRANTAHI (Grupo Antitabaquismo del Hospital Italiano), Beruti 3737, 6 floor , apt 22, Buenos Aires, Argentina, Javier Saimovici, Internal Medicine Service, Hospital Italiano de Buenos Aires, GRANTAHI (Grupo Antitabaquismo del Hospital Italiano), Beruti 3737, 6 floor , apt 22, Buenos Aires, Argentina, Flavia Vidal, Toxicology Service, Hospital Italiano de Buenos Aires, GRANTAHI (Grupo Antitabaquismo del Hospital Italiano), Beruti 3737, 6 floor , apt 22, Buenos Aires, Argentina, and Herman Schargrodsky, Cardiology, Hospital Italiano de Buenos Aires, GRANTAHI (Grupo Antitabaquismo del Hospital Italiano), Beruti 3737, 6 floor , apt 22, Buenos Aires, Argentina.

Objective: To evaluate the effectiveness of a MIGT for smoking cessation in a Latin American Country.

Methods: Voluntary smokers willing to quit, who completed the first individual appointment in the MIGT were included. MIGT is an ambulatory program with a group cognitive behavioral approach, pharmacotherapy and professional and social support skills. The program is composed by 6 weekly sessions, (2 hours each) preceded by 2 individual evaluations. A special tobacco medical chart was designed to record information Outcome measures: Smoking abstinence was reported as prevalence abstinence at one year of the quit date, and breath Carbon Monoxide monitoring We developed a multi-regression model to explore predictors of success.

Results: 437 smokers subjects (59.3% women) willing to quit who were admitted at the first visit of MIGT. Mean age was 48.6 (SD 13.9). Mean number of daily cigarette consumption was 25 (SD 13) Mean FS was 5.6 (SD 2.4). ARU showed the highest mean score in the nicotine sedative effect 6.8 (SD 2.1) . 284 patients (63%) had a complete follow-up at one year. The 37% population without follow-up complete data at one year (abstinence reported and breath CO measurement), were considered smokers. 101 patients (23.7%) were abstinent at one year. In the multivariate analysis the FS and the sedative effect of nicotine in the ARU score were predictors of relapse.